Experience

We advised the book-running manager on the equity offering

We advised the initial purchasers on the high-yield notes offering

We advised the underwriters on the SEC-registered equity offering

Davis Polk advised the joint book-running managers and representatives of the underwriters in connection with the $305.9 million secondary offering of 10,925,000 shares of common stock…

Davis Polk advised the representative of the several initial purchasers in connection with the offering by Seagate HDD Cayman of $500 million aggregate principal amount of its 3.125%…

Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with a $307 million public offering of 4,150,000 shares of common stock…

Davis Polk advised the representatives of the underwriters in connection with the $402.5 million initial public offering of 28,750,000 shares of common stock by Allegro MicroSystems,…

Davis Polk advised Royalty Pharma plc and the selling shareholders on Royalty Pharma’s $728 million secondary offering of 17,343,037 of its Class A ordinary shares by certain selling…

Davis Polk advised Pactiv Evergreen Inc. on a Rule 144A/Regulation S offering of $1.0 billion aggregate principal amount of its 4.000% senior notes due 2027 by Reynolds Group Issuer Inc…

Davis Polk advised Pactiv Evergreen Inc. (formerly known as Reynolds Group Holdings Limited) on its $574 million initial public offering of 41,026,000 shares of common stock. The shares of…